Skip to main content

Articles

Page 35 of 35

  2. Functional genomic studies are dominated by transcriptomic approaches, in part reflecting the vast amount of information that can be obtained, the ability to amplify mRNA and the availability of commercially s...

    Authors: Julian L Griffin and Christine Des Rosiers
    Citation: Genome Medicine 2009 1:32
    Content type: Review Published on:

  6. Despite the recent success of genome-wide association studies (GWASs) in identifying loci consistently associated with coronary artery disease (CAD), a large proportion of the genetic components of CAD and its...

    Authors: Matthew B Lanktree and Robert A Hegele
    Citation: Genome Medicine 2009 1:28
    Content type: Review Published on:

  10. Disparities in health outcomes of members of different ancestral or ethnic groups can be observed in both developed and developing countries and continue to be a global concern. Genomic medicine can help towar...

    Authors: David Gurwitz and Jeantine E Lunshof
    Citation: Genome Medicine 2009 1:24
    Content type: Commentary Published on:

  15. The wide general publication of a putative genetic test for athletic supremacy is clearly an abuse of genetics and reveals an undercurrent of hucksterism in biomedical science.

    Authors: David G Nathan and Stuart H Orkin
    Citation: Genome Medicine 2009 1:18
    Content type: Musings Published on:

  17. The availability of personalized genomic tests, ordered directly by consumers, is rapidly growing. These tests are unlike other genetic or biochemical tests in the sheer amount of data they provide, but interp...

    Authors: David Magnus, Mildred K Cho and Robert Cook-Deegan
    Citation: Genome Medicine 2009 1:17
    Content type: Commentary Published on:

  18. The genome era in medicine is upon us. Questions that arise from patient and family care are a watershed for research and technology, which in turn fuel the cycle of opportunity for impact through delivery of ...

    Authors: Janet A Buchanan, Andrew R Carson, David Chitayat, David Malkin, M Stephen Meyn, Peter N Ray, Cheryl Shuman, Rosanna Weksberg and Stephen W Scherer
    Citation: Genome Medicine 2009 1:16
    Content type: Editorial Published on:

  21. The Human Gene Mutation Database (HGMD®) is a comprehensive core collection of germline mutations in nuclear genes that underlie or are associated with human inherited disease. Here, we summarize the history of t...

    Authors: Peter D Stenson, Matthew Mort, Edward V Ball, Katy Howells, Andrew D Phillips, Nick ST Thomas and David N Cooper
    Citation: Genome Medicine 2009 1:13
    Content type: Correspondence Published on:

  22. It has been established that heterozygous carriers of ataxia-telangiectasia-causing mutations in the ATM gene are at approximately two-fold higher risk of breast cancer. Several studies have attempted to assess t...

    Authors: Roger L Milne
    Citation: Genome Medicine 2009 1:12
    Content type: Minireview Published on:

  23. Genome medicine uses genomic information in the diagnosis of disease and in prescribing treatment. This transdisciplinary field brings together knowledge on the relationships between genetics, pathophysiology ...

    Authors: Aislyn D Wist, Seth I Berger and Ravi Iyengar
    Citation: Genome Medicine 2009 1:11
    Content type: Review Published on:

  26. The use of race in biomedical research has, for decades, been a source of social controversy. However, recent events, such as the adoption of racially targeted pharmaceuticals, have raised the profile of the r...

    Authors: Timothy Caulfield, Stephanie M Fullerton, Sarah E Ali-Khan, Laura Arbour, Esteban G Burchard, Richard S Cooper, Billie-Jo Hardy, Simrat Harry, Robyn Hyde-Lay, Jonathan Kahn, Rick Kittles, Barbara A Koenig, Sandra SJ Lee, Michael Malinowski, Vardit Ravitsky, Pamela Sankar…
    Citation: Genome Medicine 2009 1:8
    Content type: Correspondence Published on:

  28. The Genetic Information Nondiscrimination Act of 2008 (GINA) was recently enacted in the United States. Its supporters have applauded the passage of GINA, and they hope that it will alleviate public fear about...

    Authors: Amy L McGuire and Mary Anderlik Majumder
    Citation: Genome Medicine 2009 1:6
    Content type: Commentary Published on:
Submit manuscript
  • Editorial Board
  • Editorial Team
  • Call for EBMs
  • Call for papers
  • Sign up for article alerts and news from this journal
  • Manuscript editing services
  • Contact us

  • Announcements

    C19 Rapid Review initiative

    Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here. 

    Submissions from medRxiv 

    Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.

    Portable peer review

    To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.

    COVID-19 submissions

    In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.

Follow

Annual Journal Metrics

  • 2022 Citation Impact
    12.3 - 2-year Impact Factor
    13.8 - 5-year Impact Factor
    2.422 - SNIP (Source Normalized Impact per Paper)
    4.851 - SJR (SCImago Journal Rank)

    2022 Speed
    64 days submission to first editorial decision for all manuscripts (Median)
    212 days submission to accept (Median)

    2022 Usage 
    1,991,217 downloads
    14,220 Altmetric mentions 

Genome Medicine

ISSN: 1756-994X

Contact us